On the reclassification of AMB-FUBINACA and 5F-ADB as Class A drugs Reclassification of substances to increase penalties associated with their use and supply has historically failed to reduce either use or harm. In this case, because the community most affected by these substances is already marginalised, the reclassification is likely to hurt them more, byContinue reading “KnowYourStuffNZ’s submission on the Misuse of Drugs Amendment Bill”